Passage Bio Stock Market Value
| PASG Stock | USD 0.39 0.01 2.50% |
| Symbol | Passage |
Passage Bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Passage Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Passage Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Passage Bio.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Passage Bio on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Passage Bio or generate 0.0% return on investment in Passage Bio over 90 days. Passage Bio is related to or competes with Black Diamond, Revolution Medicines, Stoke Therapeutics, and Cabaletta Bio. Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases More
Passage Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Passage Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Passage Bio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 56.48 | |||
| Value At Risk | (8.96) | |||
| Potential Upside | 7.02 |
Passage Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Passage Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Passage Bio's standard deviation. In reality, there are many statistical measures that can use Passage Bio historical prices to predict the future Passage Bio's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | 0.0833 | |||
| Treynor Ratio | (0.56) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Passage Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Passage Bio Backtested Returns
Passage Bio maintains Sharpe Ratio (i.e., Efficiency) of -0.1, which implies the firm had a -0.1 % return per unit of risk over the last 3 months. Passage Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Passage Bio's Risk Adjusted Performance of (0.09), coefficient of variation of (889.57), and Variance of 52.91 to confirm the risk estimate we provide. The company holds a Beta of 1.48, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Passage Bio will likely underperform. At this point, Passage Bio has a negative expected return of -0.78%. Please make sure to check Passage Bio's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Passage Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.44 |
Average predictability
Passage Bio has average predictability. Overlapping area represents the amount of predictability between Passage Bio time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Passage Bio price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Passage Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Passage Bio lagged returns against current returns
Autocorrelation, which is Passage Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Passage Bio's stock expected returns. We can calculate the autocorrelation of Passage Bio returns to help us make a trade decision. For example, suppose you find that Passage Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Passage Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Passage Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Passage Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Passage Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Passage Bio Lagged Returns
When evaluating Passage Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Passage Bio stock have on its future price. Passage Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Passage Bio autocorrelation shows the relationship between Passage Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Passage Bio.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Passage Bio is a strong investment it is important to analyze Passage Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Passage Bio's future performance. For an informed investment choice regarding Passage Stock, refer to the following important reports:Check out Passage Bio Correlation, Passage Bio Volatility and Passage Bio Alpha and Beta module to complement your research on Passage Bio. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Passage Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.